Devalben Patel
Overview
Explore the profile of Devalben Patel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
244
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Middha P, Thummalapalli R, Betti M, Yao L, Quandt Z, Balaratnam K, et al.
Nat Commun
. 2024 Mar;
15(1):2568.
PMID: 38531883
Immune checkpoint inhibitor-mediated colitis (IMC) is a common adverse event of treatment with immune checkpoint inhibitors (ICI). We hypothesize that genetic susceptibility to Crohn's disease (CD) and ulcerative colitis (UC)...
12.
Herman M, Lok B, Gallinger S, Dawson L, Kim R, Cheng D, et al.
Transl Gastroenterol Hepatol
. 2023 Nov;
8:32.
PMID: 38021355
Background: The prognosis of hepatocellular carcinoma (HCC) is influenced by both tumor and patient specific factors. Current therapies of advanced HCC target angiogenesis and immune evasion, however there are no...
13.
Middha P, Thummalapalli R, Betti M, Yao L, Quandt Z, Balaratnam K, et al.
medRxiv
. 2023 Jun;
PMID: 37292751
Immune checkpoint inhibitors (ICIs) are a remarkable advancement in cancer therapeutics; however, a substantial proportion of patients develop severe immune-related adverse events (irAEs). Understanding and predicting irAEs is a key...
14.
Haq S, Schmid S, Aparnathi M, Hueniken K, Zhan L, Sacdalan D, et al.
iScience
. 2022 Nov;
25(12):105487.
PMID: 36425756
Small-cell lung cancer (SCLC) methylome is understudied. Here, we comprehensively profile SCLC using cell-free methylated DNA immunoprecipitation followed by sequencing (cfMeDIP-seq). Cell-free DNA (cfDNA) from plasma of 74 patients with...
15.
Schmid S, Cheng S, Chotai S, Garcia M, Zhan L, Hueniken K, et al.
Clin Lung Cancer
. 2022 Oct;
24(1):40-50.
PMID: 36270866
Objectives: This real-world analysis describes treatment patterns, sequencing and clinical effectiveness, toxicities, and health utility outcomes in advanced-stage, incurable ALK-positive NSCLC patients across five different ALK-TKIs. Materials And Methods: Clinicodemographic,...
16.
Kuruvilla M, Liu G, Syed I, Gwadry-Sridhar F, Sheffield B, Sachdeva R, et al.
Lung Cancer
. 2022 Sep;
173:58-66.
PMID: 36152478
Objectives: The ADAURA trial demonstrated the benefit of adjuvant osimertinib among patients with resected, early-stage, epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC). To understand the potential population...
17.
Schmid S, Garcia M, Cheng S, Zhan L, Chotai S, Balaratnam K, et al.
Lung Cancer
. 2022 Feb;
166:58-62.
PMID: 35183992
Introduction: We evaluated the baseline demographics, treatment patterns, and outcomes of patients with ALK-rearranged early stage (Stage I-III) non-small cell lung cancer (NSCLC). We also evaluated the efficacy and toxicity...
18.
Zazuli Z, de Jong C, Xu W, Vijverberg S, Masereeuw R, Patel D, et al.
J Pers Med
. 2021 Nov;
11(11).
PMID: 34834585
This study aims to evaluate genetic risk factors for cisplatin-induced nephrotoxicity by investigating not previously studied genetic risk variants and further examining previously reported genetic associations. A genome-wide study (GWAS)...
19.
Schmid S, Zhan L, Dietrich K, Khan K, Chowdhury M, Herman M, et al.
Clin Lung Cancer
. 2021 Sep;
23(1):e43-e53.
PMID: 34531139
Background: Overall survival (OS) for malignant pleural mesothelioma (MPM) in vulnerable subgroups remains poorly understood with scarce data available to guide treatment decisions. The study describes real-world detailed treatment patterns...
20.
Thomas S, Carroll J, Brown M, Chen Z, Mirshams M, Patel D, et al.
PLoS One
. 2020 Aug;
15(8):e0237723.
PMID: 32857771
Purpose: This study investigated nicotine dependence as an independent risk factor for upper aerodigestive tract (UADT) cancers, including lung and head and neck cancers (HNC). The study aimed to isolate...